| Trial Status | Closed for recruitment |
| Dates | Date of activation: 02-Jan-06 Closed on : 05-Nov-09 |
| Data management at EORTC | None |
| Phase | 3 |
| Randomized trial | Yes |
| Type | Adjuvant |
| Targeted Sample size | EORTC Groups: 150 - All Groups: 2000 |
| Number of steps | 1 |
| Drug | Fluorouracil Cetuximab Leucovorin Oxaliplatin |
| Study Staff | Eric Van Cutsem (Study Coordinator) - U.Z. Leuven - Campus Gasthuisberg, Leuven Laurence Collette (Statistician) - EORTC Headquarters, Brussels Sandrine Marreaud (Coordinating Physician) - EORTC Headquarters, Brussels Michel Praet (Project Manager) - EORTC Headquarters, Brussels, michel.praet( at )eortc.be, +32 27741672 |
| Type of cancer | Colon |
| Participating Groups | Federation Francophone de Cancerologie Digestive(Coordinating Group) EORTC Gastrointestinal Tract Cancer Group Arbeitsgemeinschaft Internistische Onkologie Association Europeenne de Rcherche en Oncologie Austrian Breast and Colorectal Cancer Study Group Belgian Group of Digestive Oncology FNCLCC Grupo Coop. do Cancro Dig. da Ass. Portuguesa Inv. Onco. Grupo Espanol para el Tratamiento de Tumores Digestivos Gruppo Italiano Studio Carcinomi Apparato Digerente Gruppo Oncologico Chirurgico Cooperativo Italiano |
| Protocol summary | Cancer.gov (PDQ) ClinicalTrials.gov |
| NCT number | |
| EudraCT | 2005-003463-23 |
| Protocol documents in PDF (requires password) | Study documentation |